Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
Artiman Ventures
Palo AltoSeed–Late Stage$2M – $6M
10 people
InVivium Capital
ChicagoSeed–Late Stage
6 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
9 people
Rocket Capital
AmsterdamSeries B–Late Stage
9 people
Southern Cross Group
SantiagoGrowth–Late Stage
15 people
Quest for Growth
LeuvenGrowth–Late Stage
8 people
Rock Health Capital
San FranciscoSeed–Late Stage$500K – $3M
5 people
Nordic Capital
CopenhagenGrowth–Late Stage
7 people
Sutter Hill Ventures
Palo AltoSeed–Late Stage$100K – $5M
7 people
Massachusetts Capital Resource Co.
BostonGrowth–Late Stage$1M – $5M
3 people
Medvest Capital
Palm Beach GardensPre-Seed–Late Stage$1M – $3M
3 people
Vision Creator
SeoulPre-Seed–Late Stage
Whiz Partners Inc.
TokyoSeed–Late Stage$500K – $5M
6 people
EDB Investments
SingaporeSeed–Late Stage$12M – $400M
11 people
Next Orbit Ventures Fund-I
MumbaiSeed–Late Stage
8 people
Powerhouse Ventures
Fortitude ValleySeed–Late Stage
8 people
Narya Capital
ColumbusPre-Seed–Late Stage
2 people
ClearVision Equity
DoverSeed–Late Stage$500K – $5M
1 person
Korify Capital
Series A–Late Stage
3 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
PBM Capital
CharlottesvilleSeed–Late Stage
6 people
SBCVC
TortolaSeed–Late Stage
6 people
Shenasa
TehranLate Stage
Affinity Equity Partners
SingaporeGrowth–Late Stage$250M – $1B
5 people
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.







































